Table 1.
Clinical and Pathologic Characteristics of Patients With Initial Diagnosis of AJCC Stage III Cutaneous Melanoma
| Characteristic | No. | % |
|---|---|---|
| Age, years | ||
| Median | 57 | |
| Range | 11-95 | |
| Sex | ||
| Male | 218 | 64 |
| Female | 122 | 36 |
| Primary site | ||
| Head and neck | 50 | 15 |
| Extremities | 175 | 51 |
| Trunk | 89 | 26 |
| Mucosal | 0 | 0 |
| Unknown primary | 26 | 8 |
| Substage III (AJCC, 2002) | ||
| IIIA | 95 | 28 |
| IIIB | 155 | 46 |
| IIIC | 90 | 26 |
| Adjuvant therapy* | ||
| Interferon | 55 | 16 |
| Vaccine | 79 | 23 |
| Chemotherapy | 21 | 6 |
| Radiotherapy | 22 | 6 |
| None | 161 | 47 |
Abbreviation: AJCC, American Joint Committee on Cancer.
*
For two patients, no information was available regarding adjuvant therapy.